Part 7/9:
In a substantial move towards health improvement, the prices of inhalers in the United States are on track to drop to $35. Asthma affects millions of people, and until now, the financial burden of inhalers has been exorbitant, with costs in the U.S. being significantly higher than in many other countries.
Thanks to advocacy from various lawmakers, three out of four major inhaler manufacturers have committed to reducing prices by 2025. This change has the potential to save countless lives and make asthma management affordable for millions.